Bacitracin

   
Google
 
Web NewDrugInformation.com

Bacitracin


Drug - Bacitracin
The trade name of the product as shown on the labeling.

Dosage - POWDER; FOR RX COMPOUNDING
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bacitracin
Multiple ingredients are in alphabetical order.

Strength - 5,000,000 UNITS/BOT
The potency of the active ingredient(s), Bacitracin. May repeat for multiple part products.

Applicant - PADDOCK
The firm name holding legal responsibility for Bacitracin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062456
The FDA assigned number to Bacitracin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bacitracin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 27, 1983
The date Bacitracin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bacitracin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Bacitracin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Paddock Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Bacitracin.

Bacitracin